Thu. Nov. 19, 2020 1:00 PM – 2:00 PM Register From accelerating clinical trials and gaining regulatory approval to expanding access and understanding market needs, this webinar will cover the basics of what makes real-world data regulatory and research grade and how it can transform your R&D and market access programs for autoimmune and other[…]
October 21, 2020- ISPOR In a recent blog post from ISPOR, Richard Gliklich, CEO of OM1 and Michelle Leavy, MPH, Head of Health Policy at OM1 detail how Implementing Standardized Outcome Measures Supports Value-Based Care. Value-based care has received significant attention in recent years as an approach to improving patient outcomes while controlling healthcare costs.[…]
BOSTON, Sept. 21, 2020 /PRNewswire/ — An update of “Registries for Evaluating Patient Outcomes: A User’s Guide: 4th Edition,” was released today, the fourth edition of a reference handbook from the U.S. Agency for Healthcare Research and Quality (AHRQ) that contains practical information on the design, operation, and analysis of patient registries. First published in 2007, the User’s Guide[…]
View our poster on Assessing Comorbid Inflammatory Arthritis Conditions and Swollen to Tender Joint Count Ratios in a Real-World Systemic Lupus Erythematosus Cohort. Click to view more!
August 13, 2020- Aetion In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology. Read on[…]
